Radiation Injury Drugs Market to Expand Amid Rising Nuclear Preparedness and Advancements in Radioprotective Therapies
https://growthmarketreports.co....m/report/radiation-i
The Radiation Injury Drugs Market refers to the global pharmaceutical sector focused on developing and distributing drugs used to prevent, mitigate, or treat injuries caused by exposure to ionizing radiation. These drugs are essential in managing acute radiation syndrome (ARS), radiation burns, and long-term cellular damage resulting from nuclear exposure or radiological emergencies.
Like
Comment
Share
